NASDAQ · CUPR
Healthcare · Biotechnology
$3.20
Up+$0.05 (+1.59%)
Updated Sep 15, 2026, 3:30 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CUPR closed at $3.20 after 20 trading sessions, up 9.59% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $3.11 | $3.205 | $3.10 | $3.20 | 5.78K |
| Sep 11, 2026 | $3.00 | $3.23 | $2.9995 | $3.15 | 24.06K |
| Sep 10, 2026 | $2.99 | $3.40 | $2.9006 | $3.00 | 8.63K |
| Sep 9, 2026 | $3.18 | $3.18 | $2.90 | $2.91 | 12.08K |
| Sep 8, 2026 | $3.04 | $3.30 | $2.93 | $3.12 | 553.54K |
| Sep 4, 2026 | $3.06 | $3.17 | $2.99 | $3.16 | 25.12K |
| Sep 3, 2026 | $2.84 | $3.00 | $2.80 | $2.94 | 26.41K |
| Sep 2, 2026 | $2.85 | $3.26 | $2.62 | $2.79 | 72.17K |
| Sep 1, 2026 | $2.90 | $2.9099 | $2.81 | $2.90 | 4.9K |
| Aug 31, 2026 | $3.00 | $3.00 | $2.8375 | $2.9101 | 5.04K |
| Aug 28, 2026 | $3.05 | $3.06 | $3.00 | $3.01 | 4.3K |
| Aug 27, 2026 | $3.00 | $3.2794 | $2.95 | $3.13 | 19.64K |
| Aug 26, 2026 | $2.85 | $2.99 | $2.82 | $2.945 | 4.87K |
| Aug 25, 2026 | $2.73 | $2.94 | $2.7201 | $2.92 | 31.97K |
| Aug 24, 2026 | $2.72 | $2.74 | $2.7029 | $2.73 | 3.04K |
| Aug 21, 2026 | $2.80 | $2.89 | $2.80 | $2.875 | 5.43K |
| Aug 20, 2026 | $2.93 | $2.93 | $2.76 | $2.82 | 14.93K |
| Aug 19, 2026 | $2.87 | $2.94 | $2.71 | $2.91 | 7.75K |
| Aug 18, 2026 | $2.82 | $3.02 | $2.7168 | $2.97 | 11.54K |
| Aug 17, 2026 | $3.06 | $3.06 | $2.6601 | $2.92 | 28.73K |
The latest Smart Investors Daily articles mentioning CUPR.
CUPR research
Company profile and research snapshot.
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Aug 31, 2026
VANCOUVER, BC / ACCESS Newswire / August 31, 2026 / SUPER COPPER CORP. (CSE:CUPR)(OTCQB:CUPPF)(FSE:N60) ("Super Copper" or the "Company"), is pleased to announce that Zachary Dolesky, Founder and Chief Executive Officer, presented live at the Clean Energy & Metals Virtual Investor Conference on August 27, 2026, the proprietary investor conference series of OTC Markets Group.
Benzinga · Jul 7, 2026
https://www.sec.gov/ix?doc=/Archives/edgar/data/1995704/000149315226032280/formf-1.htm
Benzinga · Jun 16, 2026
Benzinga · Jun 16, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CUPR.
No results
No recent SID articles mention CUPR.
